Global Pharmaceutical Enzymes In Drug Development Market Research Report 2025

Publication ID:

PB505259494

Publication Date:

May 21, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Pharmaceutical Enzymes In Drug Development was valued at US$ 549 million in the year 2024 and is projected to reach a revised size of US$ 749 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Pharmaceutical enzymes play a critical role in the development of drugs by catalyzing biochemical reactions that are essential for the production, activation, or degradation of drugs. These enzymes are proteins that act as biological catalysts, speeding up chemical reactions within the body and are used in various stages of drug development, from synthesis to formulation and even in drug delivery. Enzymes are particularly useful in drug manufacturing as they can help in the selective modification of drug molecules, improve the stability of pharmaceutical formulations, and facilitate the efficient production of biopharmaceuticals such as antibodies and vaccines. Moreover, enzymes are integral to prodrug strategies, where an inactive compound is converted into its active form inside the body by specific enzymes. The use of pharmaceutical enzymes can also enhance the targeted delivery of drugs, improve bioavailability, and reduce side effects by ensuring that the drug acts only in the intended area of the body. Overall, the incorporation of enzymes in drug development has revolutionized the pharmaceutical industry by enabling more efficient, precise, and safe therapeutic options.
The market for enzymes used in drug synthesis is experiencing rapid growth, driven by the increasing adoption of green chemistry and biocatalysis in pharmaceutical production. More companies are leveraging enzyme catalysis to enhance production efficiency and reduce environmental impact. Enzymatic catalysis plays a key role in the synthesis of semi-synthetic antibiotics, antiviral drugs, and other pharmaceuticals, particularly in improving reaction specificity and minimizing by-products. Looking ahead, advancements in genetic engineering and enzyme engineering will continue to drive demand for drug synthesis enzymes, with trends toward specialized and customized enzyme formulations, broadening their application in drug development.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Enzymes In Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Enzymes In Drug Development.
The Pharmaceutical Enzymes In Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Enzymes In Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Enzymes In Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amicogen
CSPC Pharmaceutical Group
Hunan Flag Bio-technology
Yili Chuannig Biotechnology
Joincare Pharmaceutical Group
Shuangyan Pharmaceuticals
Hangzhou Junfeng Biotechnology
Segment by Type
Hydrolases
Oxidoreductases
Transferases
Others
Segment by Application
Biopharmaceuticals
Synthetic Pharmaceuticals
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Enzymes In Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Enzymes In Drug Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hydrolases
1.2.3 Oxidoreductases
1.2.4 Transferases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Enzymes In Drug Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Synthetic Pharmaceuticals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Enzymes In Drug Development Market Perspective (2020-2031)
2.2 Global Pharmaceutical Enzymes In Drug Development Growth Trends by Region
2.2.1 Global Pharmaceutical Enzymes In Drug Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Enzymes In Drug Development Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Enzymes In Drug Development Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Enzymes In Drug Development Market Dynamics
2.3.1 Pharmaceutical Enzymes In Drug Development Industry Trends
2.3.2 Pharmaceutical Enzymes In Drug Development Market Drivers
2.3.3 Pharmaceutical Enzymes In Drug Development Market Challenges
2.3.4 Pharmaceutical Enzymes In Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Enzymes In Drug Development Players by Revenue
3.1.1 Global Top Pharmaceutical Enzymes In Drug Development Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Enzymes In Drug Development Revenue Market Share by Players (2020-2025)
3.2 Global Top Pharmaceutical Enzymes In Drug Development Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Enzymes In Drug Development Revenue
3.4 Global Pharmaceutical Enzymes In Drug Development Market Concentration Ratio
3.4.1 Global Pharmaceutical Enzymes In Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Enzymes In Drug Development Revenue in 2024
3.5 Global Key Players of Pharmaceutical Enzymes In Drug Development Head office and Area Served
3.6 Global Key Players of Pharmaceutical Enzymes In Drug Development, Product and Application
3.7 Global Key Players of Pharmaceutical Enzymes In Drug Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Enzymes In Drug Development Breakdown Data by Type
4.1 Global Pharmaceutical Enzymes In Drug Development Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Enzymes In Drug Development Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Enzymes In Drug Development Breakdown Data by Application
5.1 Global Pharmaceutical Enzymes In Drug Development Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Enzymes In Drug Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Enzymes In Drug Development Market Size (2020-2031)
6.2 North America Pharmaceutical Enzymes In Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Enzymes In Drug Development Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Enzymes In Drug Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Enzymes In Drug Development Market Size (2020-2031)
7.2 Europe Pharmaceutical Enzymes In Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Enzymes In Drug Development Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Enzymes In Drug Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Enzymes In Drug Development Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Enzymes In Drug Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Enzymes In Drug Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Enzymes In Drug Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Enzymes In Drug Development Market Size (2020-2031)
9.2 Latin America Pharmaceutical Enzymes In Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Enzymes In Drug Development Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Enzymes In Drug Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Enzymes In Drug Development Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Enzymes In Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Enzymes In Drug Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Enzymes In Drug Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amicogen
11.1.1 Amicogen Company Details
11.1.2 Amicogen Business Overview
11.1.3 Amicogen Pharmaceutical Enzymes In Drug Development Introduction
11.1.4 Amicogen Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.1.5 Amicogen Recent Development
11.2 CSPC Pharmaceutical Group
11.2.1 CSPC Pharmaceutical Group Company Details
11.2.2 CSPC Pharmaceutical Group Business Overview
11.2.3 CSPC Pharmaceutical Group Pharmaceutical Enzymes In Drug Development Introduction
11.2.4 CSPC Pharmaceutical Group Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.2.5 CSPC Pharmaceutical Group Recent Development
11.3 Hunan Flag Bio-technology
11.3.1 Hunan Flag Bio-technology Company Details
11.3.2 Hunan Flag Bio-technology Business Overview
11.3.3 Hunan Flag Bio-technology Pharmaceutical Enzymes In Drug Development Introduction
11.3.4 Hunan Flag Bio-technology Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.3.5 Hunan Flag Bio-technology Recent Development
11.4 Yili Chuannig Biotechnology
11.4.1 Yili Chuannig Biotechnology Company Details
11.4.2 Yili Chuannig Biotechnology Business Overview
11.4.3 Yili Chuannig Biotechnology Pharmaceutical Enzymes In Drug Development Introduction
11.4.4 Yili Chuannig Biotechnology Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.4.5 Yili Chuannig Biotechnology Recent Development
11.5 Joincare Pharmaceutical Group
11.5.1 Joincare Pharmaceutical Group Company Details
11.5.2 Joincare Pharmaceutical Group Business Overview
11.5.3 Joincare Pharmaceutical Group Pharmaceutical Enzymes In Drug Development Introduction
11.5.4 Joincare Pharmaceutical Group Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.5.5 Joincare Pharmaceutical Group Recent Development
11.6 Shuangyan Pharmaceuticals
11.6.1 Shuangyan Pharmaceuticals Company Details
11.6.2 Shuangyan Pharmaceuticals Business Overview
11.6.3 Shuangyan Pharmaceuticals Pharmaceutical Enzymes In Drug Development Introduction
11.6.4 Shuangyan Pharmaceuticals Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.6.5 Shuangyan Pharmaceuticals Recent Development
11.7 Hangzhou Junfeng Biotechnology
11.7.1 Hangzhou Junfeng Biotechnology Company Details
11.7.2 Hangzhou Junfeng Biotechnology Business Overview
11.7.3 Hangzhou Junfeng Biotechnology Pharmaceutical Enzymes In Drug Development Introduction
11.7.4 Hangzhou Junfeng Biotechnology Revenue in Pharmaceutical Enzymes In Drug Development Business (2020-2025)
11.7.5 Hangzhou Junfeng Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Amicogen
CSPC Pharmaceutical Group
Hunan Flag Bio-technology
Yili Chuannig Biotechnology
Joincare Pharmaceutical Group
Shuangyan Pharmaceuticals
Hangzhou Junfeng Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂